Dear Doctor - Participate in the Survey on epilepsy " A new survey has found that nearly one in three people with epilepsy have experienced at least one seizure in the past year. The findings, from the Epilepsy Foundation's 2020 National Survey of Epilepsy Attitudes and Experiences, also reveal that half of all respondents worry about having a seizure in public."These survey results underscore the urgent need for improved access to care and treatments for people living with epilepsy," said Philip Gattone, CEO of the Epilepsy Foundation. "It is unacceptable that so many people with this condition are still facing challenges in getting the help they need."The survey, which was conducted online between February and March 2020, received more than 4,500 responses from people with epilepsy and their caregivers. Among other things, it found that:- 24% of respondents said they had not seen a doctor or other healthcare provider in the past year specifically for their epilepsy;- 36% said they have not been able to get all of the medication they need; and - 54% reported experiencing at least one seizure in the past year. Participate in Surveys "
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation